Obinutuzumab rescue after a severe rituximab infusion–related hypersensitivity reaction in IgG4-related ophthalmic disease - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Management of Severe Hypersensitivity Reaction to Rituximab with Obinutuzumab in Patients with IgG4-Related Ophthalmic Disease

  • By

  • Üçler Can Ateş

  • Semih Gülle

  • September 22, 2026

Share

Original Source(s)

Obinutuzumab rescue after a severe rituximab infusion–related hypersensitivity reaction in IgG4-related ophthalmic disease

  • by Üçler Can Ateş, Semih Gülle

  • September 22, 2026

Related Content

Vision Correction With Bitoric GP Lenses for Infantile Nystagmus Patients

Profilometry-Guided Scleral Lens Design for Keratoconus

Europe’s Cataract Benchmark

EUREQUO data from more than 363,000 procedures show improving visual outcomes and low complication rates across Europe

  • September 15, 2026

  • 2 min